Account
Insider Insights
08.08.2024
World’s first CRISPR-based Gene Therapy Exa-cel ...

NICE recommends gene therapy for severe beta-thalassaemia, offering hope for improved quality of lif...

Read more
Insider Insights
04.07.2024
Hemgenix becomes the first treatment to enter NHS ...

New ground-breaking gene therapy for haemophilia B enters NHS England's Innovative Medicines Fund, o...

Read more
Insider Insights
23.04.2024
NICE Approves CAR-Therapy for NHS

NICE recommends Kymriah® for routine NHS use, offering immense benefits for those with resistant B-...

Read more
Articles
09.06.2022
What is the New Innovative Medicines Fund and What...

The Innovative Medicines Fund launched on 7th June 2022 The Innovative Medicines Fund (IMF), which w...

Read more
Insider Insights
09.06.2022
UK launch of innovative medicines fund

Through the new fund, £340 million is to be made available to purchase promising, potentially life-...

Read more
Articles
26.07.2021
New Innovative Medicines Fund

NHS England, the UK’s publicly funded healthcare system, will be introducing a £340m fund dedicat...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch